Bronx, NY · Founded 2006 · Privately Held (backing)
Developer of small molecule therapeutics designed to treat Alzheimer's disease with an upstream approach. Oligomerix is based in Bronx, NY and was founded in 2006. It was valued at $11.1 million at its later-stage round in Mar 2022, the last priced event on record. It has raised $7.7 million across 2 recorded rounds; the latest was a $2.4 million seed round in Mar 2022.
PMV mark · valuation
$11.1M
Oct 2026
Priced at
its later-stage round
Mar 2022
Total raised
$7.7M
Last round
Seed Round
Mar 2022
Team — not yet on record
No current team members for Oligomerix are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Oligomerix with a free account
·Watch Oligomerix: the Monday email on marks, rounds and moves